NCT03466203
- Conditions
- Body Weight, Dyslipidemias, Hyperlipidemias, +10 more
- Locations
-
- Novartis Investigative Site Jacksonville, Florida, United States
- Novartis Investigative Site Miami, Florida, United States
- Novartis Investigative Site Overland Park, Kansas, United States
- Novartis Investigative Site Lincoln, Nebraska, United States